CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 232 filers reported holding CONMED CORP in Q1 2023. The put-call ratio across all filers is 3.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $12,521,757 | -17.2% | 180,637 | -4.4% | 0.02% | -20.0% |
| Q1 2024 | $15,124,629 | -35.1% | 188,869 | -11.3% | 0.03% | -41.2% |
| Q4 2023 | $23,309,641 | -1.7% | 212,854 | -9.5% | 0.05% | -16.4% |
| Q3 2023 | $23,719,113 | -38.5% | 235,192 | -17.2% | 0.06% | -32.2% |
| Q2 2023 | $38,578,627 | -9.8% | 283,896 | -31.1% | 0.09% | -15.9% |
| Q1 2023 | $42,775,053 | +6.7% | 411,853 | -9.0% | 0.11% | -1.8% |
| Q4 2022 | $40,095,241 | +41.8% | 452,338 | +28.2% | 0.11% | +29.8% |
| Q3 2022 | $28,282,000 | -14.3% | 352,774 | +6.9% | 0.08% | -19.2% |
| Q2 2022 | $33,013,000 | -18.0% | 330,130 | +22.6% | 0.10% | +1.0% |
| Q1 2022 | $40,250,000 | -17.6% | 269,320 | -21.8% | 0.10% | -3.7% |
| Q4 2021 | $48,838,000 | +18.1% | 344,511 | +9.8% | 0.11% | +15.1% |
| Q3 2021 | $41,347,000 | +10.8% | 313,713 | +15.5% | 0.09% | +13.4% |
| Q2 2021 | $37,324,000 | – | 271,579 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hood River Capital Management LLC | 448,126 | $38,346,000 | 1.80% |
| HealthCor Management, L.P. | 455,190 | $38,951,000 | 1.51% |
| Champlain Investment Partners, LLC | 1,452,360 | $124,278,000 | 1.04% |
| J. Goldman & Co LP | 162,771 | $13,928,000 | 0.96% |
| Granahan Investment Management | 189,925 | $16,252,000 | 0.80% |
| PURA VIDA INVESTMENTS, LLC | 50,000 | $4,279,000 | 0.65% |
| OAK RIDGE INVESTMENTS LLC | 102,797 | $8,797,000 | 0.61% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 78,722 | $6,736,000 | 0.54% |
| MOODY ALDRICH PARTNERS LLC | 23,834 | $2,039,000 | 0.52% |
| 361 CAPITAL LLC | 30,901 | $2,644,000 | 0.47% |